Tag Archives: TGC

Top 5 Energy Stocks To Watch For 2019

Jagged Peak Energy (NYSE:JAG) had its target price increased by equities researchers at Credit Suisse Group from $15.00 to $16.00 in a report released on Friday. The brokerage presently has a “neutral” rating on the mining company’s stock. Credit Suisse Group’s price objective would suggest a potential upside of 10.34% from the stock’s previous close.

A number of other research analysts have also weighed in on JAG. ValuEngine raised shares of Jagged Peak Energy from a “sell” rating to a “hold” rating in a research report on Wednesday,....More>>>

Top 10 Value Stocks To Own Right Now

Ant Financial Services Group, operator of China’s biggest online payment platform by market share, Alipay, has closed its latest funding round having raised $10 billion from a clutch of global and local investors, five people with direct knowledge of the matter told Reuters.

Ant’s first fundraising targeting global money values the firm at $150 billion, the people said, compared with about $60 billion after its previous fundraising in April 2016.

A number of global sovereign wealth funds and private equity firms joined the fundraising as main investors. They include....More>>>

Best Medical Stocks To Buy Right Now

Shares of Suven Life Sciences gained nearly 2 percent intraday Wednesday as company secured product patents in Australia, Eurasia and Europe.

The company has been granted 1 product patent each from Australia, Eurasia and Europe corresponding to the new chemical entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034.

The granted claims of the patents include the class of selective 5-HT4 compound.

We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena....More>>>

Top Energy Stocks To Buy Right Now

Markets have rebounded, and volatility has settled. That’s very good news for the IPO market, which is especially impacted by market turmoil.

Right now, we’re in annual February lull, and companies are putting off IPOs to finalize full 2017 financials and get past the Presidents’ Day holiday. The week’s four offerings included two SPACs (raising $450 million) and two small healthcare companies ($30 million). Fast-growing pharmaceutical Biofrontera (Pending:BFRA) soared 43%, while pre-revenue device company Motus GI (Pending:MOTS) plummeted 20%.

IPO performance....More>>>